Global Cancer Treatment Drugs Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023

Publisher Name :
Date: 07-Sep-2018
No. of pages: 147

Cancer Treatment Drugs are used to treat malignancies, or cancerous growths. Depending on the technology it cans classification into Chemotherapy, Targeted Therapy, Immunotherapy (Biologic Therapy), Hormonal Therapy and Others.

Scope of the Report:

This report focuses on the Cancer Treatment Drugs in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.

The classification of cancer treatment drugs includes chemotherapy, targeted therapy, immunotherapy, hormonal therapy and others, and the revenue proportion of chemotherapy in 2016 is about 51%.

Cancer treatment drugs are widely used for blood cancer, breast cancer, gastrointestinal cancer, prostate cancer, respiratory/lung cancer and other cancers. Amongst these different cancer types, blood cancer was the largest revenue generating segment in 2016, and the revenue market share is about 22%. The growth of blood cancer segment is majorly due to the high cost of the drugs used to treat blood cancer.

Europe region is the largest supplier of cancer treatment drugs, with a revenue market share nearly 47% in 2016. North America is the second largest supplier of cancer treatment drugs, enjoying revenue market share nearly 34% in 2016. Japan region is also holding the monopoly position around the world.

North America is the largest consumption place, with the consumption market share nearly 43% in 2016, and North America market size reached 46 billion USD. China, India and Southeast Asia are the emerging markets, and enjoy higher grow rate.

The worldwide market for Cancer Treatment Drugs is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2023, from xx million US$ in 2017, according to a new GIR (Global Info Research) study.

Market Segment by Manufacturers, this report covers

- Roche

- Novartis

- Celgene

- Bristol-Myers Squibb

- Amgen

- Johnson & Johnson

- Pfizer

- Takeda

- Eli Lilly

- AstraZeneca

- Astellas

- Merck & Co.

- Sanofi

- Bayer

- Biogen Idec

- Eisai

- Teva

- Otsuka

- Merck KGaA

- Ipsen

- AbbVie

- Gilead Sciences

Market Segment by Regions, regional analysis covers

- North America (United States, Canada and Mexico)

- Europe (Germany, France, UK, Russia and Italy)

- Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

- South America (Brazil, Argentina, Colombia etc.)

- Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers

- Chemotherapy

- Targeted Therapy

- Immunotherapy

- Hormonal Therapy (Biologic Therapy)

- Others

Market Segment by Applications, can be divided into

- Blood Cancer

- Breast Cancer

- Gastrointestinal Cancer

- Prostate Cancer

- Respiratory/Lung Cancer

- Other Cancers

There are 15 Chapters to deeply display the global Cancer Treatment Drugs market.

Chapter 1, to describe Cancer Treatment Drugs Introduction, product scope, market overview, market opportunities, market risk, market driving force;

Chapter 2, to analyze the top manufacturers of Cancer Treatment Drugs, with sales, revenue, and price of Cancer Treatment Drugs, in 2016 and 2017;

Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;

Chapter 4, to show the global market by regions, with sales, revenue and market share of Cancer Treatment Drugs, for each region, from 2013 to 2018;

Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;

Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;

Chapter 12, Cancer Treatment Drugs market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;

Chapter 13, 14 and 15, to describe Cancer Treatment Drugs sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source

Global Cancer Treatment Drugs Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023

Table of Contents
1 Market Overview
1.1 Cancer Treatment Drugs Introduction
1.2 Market Analysis by Type
1.2.1 Chemotherapy
1.2.2 Targeted Therapy
1.2.3 Immunotherapy
1.2.4 Hormonal Therapy (Biologic Therapy)
1.2.5 Others
1.3 Market Analysis by Applications
1.3.1 Blood Cancer
1.3.2 Breast Cancer
1.3.3 Gastrointestinal Cancer
1.3.4 Prostate Cancer
1.3.5 Respiratory/Lung Cancer
1.3.6 Other Cancers
1.4 Market Analysis by Regions
1.4.1 North America (United States, Canada and Mexico)
1.4.1.1 United States Market States and Outlook (2013-2023)
1.4.1.2 Canada Market States and Outlook (2013-2023)
1.4.1.3 Mexico Market States and Outlook (2013-2023)
1.4.2 Europe (Germany, France, UK, Russia and Italy)
1.4.2.1 Germany Market States and Outlook (2013-2023)
1.4.2.2 France Market States and Outlook (2013-2023)
1.4.2.3 UK Market States and Outlook (2013-2023)
1.4.2.4 Russia Market States and Outlook (2013-2023)
1.4.2.5 Italy Market States and Outlook (2013-2023)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.3.1 China Market States and Outlook (2013-2023)
1.4.3.2 Japan Market States and Outlook (2013-2023)
1.4.3.3 Korea Market States and Outlook (2013-2023)
1.4.3.4 India Market States and Outlook (2013-2023)
1.4.3.5 Southeast Asia Market States and Outlook (2013-2023)
1.4.4 South America, Middle East and Africa
1.4.4.1 Brazil Market States and Outlook (2013-2023)
1.4.4.2 Egypt Market States and Outlook (2013-2023)
1.4.4.3 Saudi Arabia Market States and Outlook (2013-2023)
1.4.4.4 South Africa Market States and Outlook (2013-2023)
1.4.4.5 Nigeria Market States and Outlook (2013-2023)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Roche
2.1.1 Business Overview
2.1.2 Cancer Treatment Drugs Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Roche Cancer Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.2 Novartis
2.2.1 Business Overview
2.2.2 Cancer Treatment Drugs Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Novartis Cancer Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.3 Celgene
2.3.1 Business Overview
2.3.2 Cancer Treatment Drugs Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Celgene Cancer Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.4 Bristol-Myers Squibb
2.4.1 Business Overview
2.4.2 Cancer Treatment Drugs Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Bristol-Myers Squibb Cancer Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.5 Amgen
2.5.1 Business Overview
2.5.2 Cancer Treatment Drugs Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Amgen Cancer Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.6 Johnson & Johnson
2.6.1 Business Overview
2.6.2 Cancer Treatment Drugs Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Johnson & Johnson Cancer Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.7 Pfizer
2.7.1 Business Overview
2.7.2 Cancer Treatment Drugs Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 Pfizer Cancer Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.8 Takeda
2.8.1 Business Overview
2.8.2 Cancer Treatment Drugs Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 Takeda Cancer Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.9 Eli Lilly
2.9.1 Business Overview
2.9.2 Cancer Treatment Drugs Type and Applications
2.9.2.1 Product A
2.9.2.2 Product B
2.9.3 Eli Lilly Cancer Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.10 AstraZeneca
2.10.1 Business Overview
2.10.2 Cancer Treatment Drugs Type and Applications
2.10.2.1 Product A
2.10.2.2 Product B
2.10.3 AstraZeneca Cancer Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.11 Astellas
2.11.1 Business Overview
2.11.2 Cancer Treatment Drugs Type and Applications
2.11.2.1 Product A
2.11.2.2 Product B
2.11.3 Astellas Cancer Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.12 Merck & Co.
2.12.1 Business Overview
2.12.2 Cancer Treatment Drugs Type and Applications
2.12.2.1 Product A
2.12.2.2 Product B
2.12.3 Merck & Co. Cancer Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.13 Sanofi
2.13.1 Business Overview
2.13.2 Cancer Treatment Drugs Type and Applications
2.13.2.1 Product A
2.13.2.2 Product B
2.13.3 Sanofi Cancer Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.14 Bayer
2.14.1 Business Overview
2.14.2 Cancer Treatment Drugs Type and Applications
2.14.2.1 Product A
2.14.2.2 Product B
2.14.3 Bayer Cancer Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.15 Biogen Idec
2.15.1 Business Overview
2.15.2 Cancer Treatment Drugs Type and Applications
2.15.2.1 Product A
2.15.2.2 Product B
2.15.3 Biogen Idec Cancer Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.16 Eisai
2.16.1 Business Overview
2.16.2 Cancer Treatment Drugs Type and Applications
2.16.2.1 Product A
2.16.2.2 Product B
2.16.3 Eisai Cancer Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.17 Teva
2.17.1 Business Overview
2.17.2 Cancer Treatment Drugs Type and Applications
2.17.2.1 Product A
2.17.2.2 Product B
2.17.3 Teva Cancer Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.18 Otsuka
2.18.1 Business Overview
2.18.2 Cancer Treatment Drugs Type and Applications
2.18.2.1 Product A
2.18.2.2 Product B
2.18.3 Otsuka Cancer Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.19 Merck KGaA
2.19.1 Business Overview
2.19.2 Cancer Treatment Drugs Type and Applications
2.19.2.1 Product A
2.19.2.2 Product B
2.19.3 Merck KGaA Cancer Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.20 Ipsen
2.20.1 Business Overview
2.20.2 Cancer Treatment Drugs Type and Applications
2.20.2.1 Product A
2.20.2.2 Product B
2.20.3 Ipsen Cancer Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.21 AbbVie
2.21.1 Business Overview
2.2.2 Cancer Treatment Drugs Type and Applications
2.21.2.1 Product A
2.21.2.2 Product B
2.21.3 AbbVie Cancer Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.22 Gilead Sciences
2.22.1 Business Overview
2.22.2 Cancer Treatment Drugs Type and Applications
2.22.2.1 Product A
2.22.2.2 Product B
2.22.3 Gilead Sciences Cancer Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
3 Global Cancer Treatment Drugs Sales, Revenue, Market Share and Competition by Manufacturer (2016-2017)
3.1 Global Cancer Treatment Drugs Sales and Market Share by Manufacturer (2016-2017)
3.2 Global Cancer Treatment Drugs Revenue and Market Share by Manufacturer (2016-2017)
3.3 Market Concentration Rate
3.3.1 Top 3 Cancer Treatment Drugs Manufacturer Market Share in 2017
3.3.2 Top 6 Cancer Treatment Drugs Manufacturer Market Share in 2017
3.4 Market Competition Trend
4 Global Cancer Treatment Drugs Market Analysis by Regions
4.1 Global Cancer Treatment Drugs Sales, Revenue and Market Share by Regions
4.1.1 Global Cancer Treatment Drugs Sales and Market Share by Regions (2013-2018)
4.1.2 Global Cancer Treatment Drugs Revenue and Market Share by Regions (2013-2018)
4.2 North America Cancer Treatment Drugs Sales and Growth Rate (2013-2018)
4.3 Europe Cancer Treatment Drugs Sales and Growth Rate (2013-2018)
4.4 Asia-Pacific Cancer Treatment Drugs Sales and Growth Rate (2013-2018)
4.5 South America Cancer Treatment Drugs Sales and Growth Rate (2013-2018)
4.6 Middle East and Africa Cancer Treatment Drugs Sales and Growth Rate (2013-2018)
5 North America Cancer Treatment Drugs by Countries
5.1 North America Cancer Treatment Drugs Sales, Revenue and Market Share by Countries
5.1.1 North America Cancer Treatment Drugs Sales and Market Share by Countries (2013-2018)
5.1.2 North America Cancer Treatment Drugs Revenue and Market Share by Countries (2013-2018)
5.2 United States Cancer Treatment Drugs Sales and Growth Rate (2013-2018)
5.3 Canada Cancer Treatment Drugs Sales and Growth Rate (2013-2018)
5.4 Mexico Cancer Treatment Drugs Sales and Growth Rate (2013-2018)
6 Europe Cancer Treatment Drugs by Countries
6.1 Europe Cancer Treatment Drugs Sales, Revenue and Market Share by Countries
6.1.1 Europe Cancer Treatment Drugs Sales and Market Share by Countries (2013-2018)
6.1.2 Europe Cancer Treatment Drugs Revenue and Market Share by Countries (2013-2018)
6.2 Germany Cancer Treatment Drugs Sales and Growth Rate (2013-2018)
6.3 UK Cancer Treatment Drugs Sales and Growth Rate (2013-2018)
6.4 France Cancer Treatment Drugs Sales and Growth Rate (2013-2018)
6.5 Russia Cancer Treatment Drugs Sales and Growth Rate (2013-2018)
6.6 Italy Cancer Treatment Drugs Sales and Growth Rate (2013-2018)
7 Asia-Pacific Cancer Treatment Drugs by Countries
7.1 Asia-Pacific Cancer Treatment Drugs Sales, Revenue and Market Share by Countries
7.1.1 Asia-Pacific Cancer Treatment Drugs Sales and Market Share by Countries (2013-2018)
7.1.2 Asia-Pacific Cancer Treatment Drugs Revenue and Market Share by Countries (2013-2018)
7.2 China Cancer Treatment Drugs Sales and Growth Rate (2013-2018)
7.3 Japan Cancer Treatment Drugs Sales and Growth Rate (2013-2018)
7.4 Korea Cancer Treatment Drugs Sales and Growth Rate (2013-2018)
7.5 India Cancer Treatment Drugs Sales and Growth Rate (2013-2018)
7.6 Southeast Asia Cancer Treatment Drugs Sales and Growth Rate (2013-2018)
8 South America Cancer Treatment Drugs by Countries
8.1 South America Cancer Treatment Drugs Sales, Revenue and Market Share by Countries
8.1.1 South America Cancer Treatment Drugs Sales and Market Share by Countries (2013-2018)
8.1.2 South America Cancer Treatment Drugs Revenue and Market Share by Countries (2013-2018)
8.2 Brazil Cancer Treatment Drugs Sales and Growth Rate (2013-2018)
8.3 Argentina Cancer Treatment Drugs Sales and Growth Rate (2013-2018)
8.4 Colombia Cancer Treatment Drugs Sales and Growth Rate (2013-2018)
9 Middle East and Africa Cancer Treatment Drugs by Countries
9.1 Middle East and Africa Cancer Treatment Drugs Sales, Revenue and Market Share by Countries
9.1.1 Middle East and Africa Cancer Treatment Drugs Sales and Market Share by Countries (2013-2018)
9.1.2 Middle East and Africa Cancer Treatment Drugs Revenue and Market Share by Countries (2013-2018)
9.2 Saudi Arabia Cancer Treatment Drugs Sales and Growth Rate (2013-2018)
9.3 UAE Cancer Treatment Drugs Sales and Growth Rate (2013-2018)
9.4 Egypt Cancer Treatment Drugs Sales and Growth Rate (2013-2018)
9.5 Nigeria Cancer Treatment Drugs Sales and Growth Rate (2013-2018)
9.6 South Africa Cancer Treatment Drugs Sales and Growth Rate (2013-2018)
10 Global Cancer Treatment Drugs Market Segment by Type
10.1 Global Cancer Treatment Drugs Sales, Revenue and Market Share by Type (2013-2018)
10.1.1 Global Cancer Treatment Drugs Sales and Market Share by Type (2013-2018)
10.1.2 Global Cancer Treatment Drugs Revenue and Market Share by Type (2013-2018)
10.2 Chemotherapy Sales Growth and Price
10.2.1 Global Chemotherapy Sales Growth (2013-2018)
10.2.2 Global Chemotherapy Price (2013-2018)
10.3 Targeted Therapy Sales Growth and Price
10.3.1 Global Targeted Therapy Sales Growth (2013-2018)
10.3.2 Global Targeted Therapy Price (2013-2018)
10.4 Immunotherapy Sales Growth and Price
10.4.1 Global Immunotherapy Sales Growth (2013-2018)
10.4.2 Global Immunotherapy Price (2013-2018)
10.5 Hormonal Therapy (Biologic Therapy) Sales Growth and Price
10.5.1 Global Hormonal Therapy (Biologic Therapy) Sales Growth (2013-2018)
10.5.2 Global Hormonal Therapy (Biologic Therapy) Price (2013-2018)
10.6 Others Sales Growth and Price
10.6.1 Global Others Sales Growth (2013-2018)
10.6.2 Global Others Price (2013-2018)
11 Global Cancer Treatment Drugs Market Segment by Application
11.1 Global Cancer Treatment Drugs Sales Market Share by Application (2013-2018)
11.2 Blood Cancer Sales Growth (2013-2018)
11.3 Breast Cancer Sales Growth (2013-2018)
11.4 Gastrointestinal Cancer Sales Growth (2013-2018)
11.5 Prostate Cancer Sales Growth (2013-2018)
11.6 Respiratory/Lung Cancer Sales Growth (2013-2018)
11.7 Other Cancers Sales Growth (2013-2018)
12 Cancer Treatment Drugs Market Forecast (2018-2023)
12.1 Global Cancer Treatment Drugs Sales, Revenue and Growth Rate (2018-2023)
12.2 Cancer Treatment Drugs Market Forecast by Regions (2018-2023)
12.2.1 North America Cancer Treatment Drugs Market Forecast (2018-2023)
12.2.2 Europe Cancer Treatment Drugs Market Forecast (2018-2023)
12.2.3 Asia-Pacific Cancer Treatment Drugs Market Forecast (2018-2023)
12.2.4 South America Cancer Treatment Drugs Market Forecast (2018-2023)
12.2.5 Middle East and Africa Cancer Treatment Drugs Market Forecast (2018-2023)
12.3 Cancer Treatment Drugs Market Forecast by Type (2018-2023)
12.3.1 Global Cancer Treatment Drugs Sales Forecast by Type (2018-2023)
12.3.2 Global Cancer Treatment Drugs Market Share Forecast by Type (2018-2023)
12.4 Cancer Treatment Drugs Market Forecast by Application (2018-2023)
12.4.1 Global Cancer Treatment Drugs Sales Forecast by Application (2018-2023)
12.4.2 Global Cancer Treatment Drugs Market Share Forecast by Application (2018-2023)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
List of Tables and Figures
Figure Cancer Treatment Drugs Picture
Table Product Specifications of Cancer Treatment Drugs
Figure Global Sales Market Share of Cancer Treatment Drugs by Types in 2017
Table Cancer Treatment Drugs Types for Major Manufacturers
Figure Chemotherapy Picture
Figure Targeted Therapy Picture
Figure Immunotherapy Picture
Figure Hormonal Therapy (Biologic Therapy) Picture
Figure Others Picture
Figure Cancer Treatment Drugs Sales Market Share by Applications in 2017
Figure Blood Cancer Picture
Figure Breast Cancer Picture
Figure Gastrointestinal Cancer Picture
Figure Prostate Cancer Picture
Figure Respiratory/Lung Cancer Picture
Figure Other Cancers Picture
Figure United States Cancer Treatment Drugs Revenue (Value) and Growth Rate (2013-2023)
Figure Canada Cancer Treatment Drugs Revenue (Value) and Growth Rate (2013-2023)
Figure Mexico Cancer Treatment Drugs Revenue (Value) and Growth Rate (2013-2023)
Figure Germany Cancer Treatment Drugs Revenue (Value) and Growth Rate (2013-2023)
Figure France Cancer Treatment Drugs Revenue (Value) and Growth Rate (2013-2023)
Figure UK Cancer Treatment Drugs Revenue (Value) and Growth Rate (2013-2023)
Figure Russia Cancer Treatment Drugs Revenue (Value) and Growth Rate (2013-2023)
Figure Italy Cancer Treatment Drugs Revenue (Value) and Growth Rate (2013-2023)
Figure China Cancer Treatment Drugs Revenue (Value) and Growth Rate (2013-2023)
Figure Japan Cancer Treatment Drugs Revenue (Value) and Growth Rate (2013-2023)
Figure Korea Cancer Treatment Drugs Revenue (Value) and Growth Rate (2013-2023)
Figure India Cancer Treatment Drugs Revenue (Value) and Growth Rate (2013-2023)
Figure Southeast Asia Cancer Treatment Drugs Revenue (Value) and Growth Rate (2013-2023)
Figure Brazil Cancer Treatment Drugs Revenue (Value) and Growth Rate (2013-2023)
Figure Egypt Cancer Treatment Drugs Revenue (Value) and Growth Rate (2013-2023)
Figure Saudi Arabia Cancer Treatment Drugs Revenue (Value) and Growth Rate (2013-2023)
Figure South Africa Cancer Treatment Drugs Revenue (Value) and Growth Rate (2013-2023)
Figure Nigeria Cancer Treatment Drugs Revenue (Value) and Growth Rate (2013-2023)
Table Roche Basic Information, Manufacturing Base and Competitors
Table Roche Cancer Treatment Drugs Type and Applications
Table Roche Cancer Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Novartis Basic Information, Manufacturing Base and Competitors
Table Novartis Cancer Treatment Drugs Type and Applications
Table Novartis Cancer Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Celgene Basic Information, Manufacturing Base and Competitors
Table Celgene Cancer Treatment Drugs Type and Applications
Table Celgene Cancer Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Bristol-Myers Squibb Basic Information, Manufacturing Base and Competitors
Table Bristol-Myers Squibb Cancer Treatment Drugs Type and Applications
Table Bristol-Myers Squibb Cancer Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Amgen Basic Information, Manufacturing Base and Competitors
Table Amgen Cancer Treatment Drugs Type and Applications
Table Amgen Cancer Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Johnson & Johnson Basic Information, Manufacturing Base and Competitors
Table Johnson & Johnson Cancer Treatment Drugs Type and Applications
Table Johnson & Johnson Cancer Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Pfizer Basic Information, Manufacturing Base and Competitors
Table Pfizer Cancer Treatment Drugs Type and Applications
Table Pfizer Cancer Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Takeda Basic Information, Manufacturing Base and Competitors
Table Takeda Cancer Treatment Drugs Type and Applications
Table Takeda Cancer Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Eli Lilly Basic Information, Manufacturing Base and Competitors
Table Eli Lilly Cancer Treatment Drugs Type and Applications
Table Eli Lilly Cancer Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table AstraZeneca Basic Information, Manufacturing Base and Competitors
Table AstraZeneca Cancer Treatment Drugs Type and Applications
Table AstraZeneca Cancer Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Astellas Basic Information, Manufacturing Base and Competitors
Table Astellas Cancer Treatment Drugs Type and Applications
Table Astellas Cancer Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Merck & Co. Basic Information, Manufacturing Base and Competitors
Table Merck & Co. Cancer Treatment Drugs Type and Applications
Table Merck & Co. Cancer Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Sanofi Basic Information, Manufacturing Base and Competitors
Table Sanofi Cancer Treatment Drugs Type and Applications
Table Sanofi Cancer Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Bayer Basic Information, Manufacturing Base and Competitors
Table Bayer Cancer Treatment Drugs Type and Applications
Table Bayer Cancer Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Biogen Idec Basic Information, Manufacturing Base and Competitors
Table Biogen Idec Cancer Treatment Drugs Type and Applications
Table Biogen Idec Cancer Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Eisai Basic Information, Manufacturing Base and Competitors
Table Eisai Cancer Treatment Drugs Type and Applications
Table Eisai Cancer Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Teva Basic Information, Manufacturing Base and Competitors
Table Teva Cancer Treatment Drugs Type and Applications
Table Teva Cancer Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Otsuka Basic Information, Manufacturing Base and Competitors
Table Otsuka Cancer Treatment Drugs Type and Applications
Table Otsuka Cancer Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Merck KGaA Basic Information, Manufacturing Base and Competitors
Table Merck KGaA Cancer Treatment Drugs Type and Applications
Table Merck KGaA Cancer Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Ipsen Basic Information, Manufacturing Base and Competitors
Table Ipsen Cancer Treatment Drugs Type and Applications
Table Ipsen Cancer Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table AbbVie Basic Information, Manufacturing Base and Competitors
Table AbbVie Cancer Treatment Drugs Type and Applications
Table AbbVie Cancer Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Gilead Sciences Basic Information, Manufacturing Base and Competitors
Table Gilead Sciences Cancer Treatment Drugs Type and Applications
Table Gilead Sciences Cancer Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Global Cancer Treatment Drugs Sales by Manufacturer (2016-2017)
Figure Global Cancer Treatment Drugs Sales Market Share by Manufacturer in 2016
Figure Global Cancer Treatment Drugs Sales Market Share by Manufacturer in 2017
Table Global Cancer Treatment Drugs Revenue by Manufacturer (2016-2017)
Figure Global Cancer Treatment Drugs Revenue Market Share by Manufacturer in 2016
Figure Global Cancer Treatment Drugs Revenue Market Share by Manufacturer in 2017
Figure Top 3 Cancer Treatment Drugs Manufacturer (Revenue) Market Share in 2017
Figure Top 6 Cancer Treatment Drugs Manufacturer (Revenue) Market Share in 2017
Figure Global Cancer Treatment Drugs Sales and Growth Rate (2013-2018)
Figure Global Cancer Treatment Drugs Revenue and Growth Rate (2013-2018)
Table Global Cancer Treatment Drugs Sales by Regions (2013-2018)
Table Global Cancer Treatment Drugs Sales Market Share by Regions (2013-2018)
Table Global Cancer Treatment Drugs Revenue by Regions (2013-2018)
Figure Global Cancer Treatment Drugs Revenue Market Share by Regions in 2013
Figure Global Cancer Treatment Drugs Revenue Market Share by Regions in 2017
Figure North America Cancer Treatment Drugs Sales and Growth Rate (2013-2018)
Figure Europe Cancer Treatment Drugs Sales and Growth Rate (2013-2018)
Figure Asia-Pacific Cancer Treatment Drugs Sales and Growth Rate (2013-2018)
Figure South America Cancer Treatment Drugs Sales and Growth Rate (2013-2018)
Figure Middle East and Africa Cancer Treatment Drugs Sales and Growth Rate (2013-2018)
Figure North America Cancer Treatment Drugs Revenue and Growth Rate (2013-2018)
Table North America Cancer Treatment Drugs Sales by Countries (2013-2018)
Table North America Cancer Treatment Drugs Sales Market Share by Countries (2013-2018)
Figure North America Cancer Treatment Drugs Sales Market Share by Countries in 2013
Figure North America Cancer Treatment Drugs Sales Market Share by Countries in 2017
Table North America Cancer Treatment Drugs Revenue by Countries (2013-2018)
Table North America Cancer Treatment Drugs Revenue Market Share by Countries (2013-2018)
Figure North America Cancer Treatment Drugs Revenue Market Share by Countries in 2013
Figure North America Cancer Treatment Drugs Revenue Market Share by Countries in 2017
Figure United States Cancer Treatment Drugs Sales and Growth Rate (2013-2018)
Figure Canada Cancer Treatment Drugs Sales and Growth Rate (2013-2018)
Figure Mexico Cancer Treatment Drugs Sales and Growth Rate (2013-2018)
Figure Europe Cancer Treatment Drugs Revenue and Growth Rate (2013-2018)
Table Europe Cancer Treatment Drugs Sales by Countries (2013-2018)
Table Europe Cancer Treatment Drugs Sales Market Share by Countries (2013-2018)
Table Europe Cancer Treatment Drugs Revenue by Countries (2013-2018)
Figure Europe Cancer Treatment Drugs Revenue Market Share by Countries in 2016
Figure Europe Cancer Treatment Drugs Revenue Market Share by Countries in 2017
Figure Germany Cancer Treatment Drugs Sales and Growth Rate (2013-2018)
Figure UK Cancer Treatment Drugs Sales and Growth Rate (2013-2018)
Figure France Cancer Treatment Drugs Sales and Growth Rate (2013-2018)
Figure Russia Cancer Treatment Drugs Sales and Growth Rate (2013-2018)
Figure Italy Cancer Treatment Drugs Sales and Growth Rate (2013-2018)
Figure Asia-Pacific Cancer Treatment Drugs Revenue and Growth Rate (2013-2018)
Table Asia-Pacific Cancer Treatment Drugs Sales by Countries (2013-2018)
Table Asia-Pacific Cancer Treatment Drugs Sales Market Share by Countries (2013-2018)
Figure Asia-Pacific Cancer Treatment Drugs Sales Market Share by Countries 2017
Table Asia-Pacific Cancer Treatment Drugs Revenue by Countries (2013-2018)
Figure Asia-Pacific Cancer Treatment Drugs Revenue Market Share by Countries 2017
Figure China Cancer Treatment Drugs Sales and Growth Rate (2013-2018)
Figure Japan Cancer Treatment Drugs Sales and Growth Rate (2013-2018)
Figure Korea Cancer Treatment Drugs Sales and Growth Rate (2013-2018)
Figure India Cancer Treatment Drugs Sales and Growth Rate (2013-2018)
Figure Southeast Asia Cancer Treatment Drugs Sales and Growth Rate (2013-2018)
Figure South America Cancer Treatment Drugs Revenue and Growth Rate (2013-2018)
Table South America Cancer Treatment Drugs Sales by Countries (2013-2018)
Table South America Cancer Treatment Drugs Sales Market Share by Countries (2013-2018)
Figure South America Cancer Treatment Drugs Sales Market Share by Countries in 2017
Table South America Cancer Treatment Drugs Revenue by Countries (2013-2018)
Table South America Cancer Treatment Drugs Revenue Market Share by Countries (2013-2018)
Figure South America Cancer Treatment Drugs Revenue Market Share by Countries in 2017
Figure Brazil Cancer Treatment Drugs Sales and Growth Rate (2013-2018)
Figure Argentina Cancer Treatment Drugs Sales and Growth Rate (2013-2018)
Figure Colombia Cancer Treatment Drugs Sales and Growth Rate (2013-2018)
Figure Middle East and Africa Cancer Treatment Drugs Revenue and Growth Rate (2013-2018)
Table Middle East and Africa Cancer Treatment Drugs Sales by Countries (2013-2018)
Table Middle East and Africa Cancer Treatment Drugs Sales Market Share by Countries (2013-2018)
Figure Middle East and Africa Cancer Treatment Drugs Sales Market Share by Countries in 2017
Table Middle East and Africa Cancer Treatment Drugs Revenue by Countries (2013-2018)
Table Middle East and Africa Cancer Treatment Drugs Revenue Market Share by Countries (2013-2018)
Figure Middle East and Africa Cancer Treatment Drugs Revenue Market Share by Countries in 2013
Figure Middle East and Africa Cancer Treatment Drugs Revenue Market Share by Countries in 2017
Figure Saudi Arabia Cancer Treatment Drugs Sales and Growth Rate (2013-2018)
Figure UAE Cancer Treatment Drugs Sales and Growth Rate (2013-2018)
Figure Egypt Cancer Treatment Drugs Sales and Growth Rate (2013-2018)
Figure Nigeria Cancer Treatment Drugs Sales and Growth Rate (2013-2018)
Figure South Africa Cancer Treatment Drugs Sales and Growth Rate (2013-2018)
Table Global Cancer Treatment Drugs Sales by Type (2013-2018)
Table Global Cancer Treatment Drugs Sales Share by Type (2013-2018)
Table Global Cancer Treatment Drugs Revenue by Type (2013-2018)
Table Global Cancer Treatment Drugs Revenue Share by Type (2013-2018)
Figure Global Chemotherapy Sales Growth (2013-2018)
Figure Global Chemotherapy Price (2013-2018)
Figure Global Targeted Therapy Sales Growth (2013-2018)
Figure Global Targeted Therapy Price (2013-2018)
Figure Global Immunotherapy Sales Growth (2013-2018)
Figure Global Immunotherapy Price (2013-2018)
Figure Global Hormonal Therapy (Biologic Therapy) Sales Growth (2013-2018)
Figure Global Hormonal Therapy (Biologic Therapy) Price (2013-2018)
Figure Global Others Sales Growth (2013-2018)
Figure Global Others Price (2013-2018)
Table Global Cancer Treatment Drugs Sales by Application (2013-2018)
Table Global Cancer Treatment Drugs Sales Share by Application (2013-2018)
Figure Global Breast Cancer Sales Growth (2013-2018)
Figure Global Gastrointestinal Cancer Sales Growth (2013-2018)
Figure Global Prostate Cancer Sales Growth (2013-2018)
Figure Global Respiratory/Lung Cancer Sales Growth (2013-2018)
Figure Global Other Cancers Sales Growth (2013-2018)
Figure Global Cancer Treatment Drugs Sales, Revenue and Growth Rate (2018-2023)
Table Global Cancer Treatment Drugs Sales Forecast by Regions (2018-2023)
Table Global Cancer Treatment Drugs Market Share Forecast by Regions (2018-2023)
Figure North America Sales Cancer Treatment Drugs Market Forecast (2018-2023)
Figure Europe Sales Cancer Treatment Drugs Market Forecast (2018-2023)
Figure Asia-Pacific Sales Cancer Treatment Drugs Market Forecast (2018-2023)
Figure South America Sales Cancer Treatment Drugs Market Forecast (2018-2023)
Figure Middle East and Africa Sales Cancer Treatment Drugs Market Forecast (2018-2023)
Table Global Cancer Treatment Drugs Sales Forecast by Type (2018-2023)
Table Global Cancer Treatment Drugs Market Share Forecast by Type (2018-2023)
Table Global Cancer Treatment Drugs Sales Forecast by Application (2018-2023)
Table Global Cancer Treatment Drugs Market Share Forecast by Application (2018-2023)
Table Distributors/Traders/ Dealers List
  • 2018-2023 Global Doxorubicin Consumption Market Report
    Published: 15-Oct-2018        Price: US 4660 Onwards        Pages: 138
    In this report, LP Information covers the present scenario (with the base year being 2017) and the growth prospects of global Doxorubicin market for 2018-2023. Doxorubicin is a kind of antitumor antibiotics, can inhibit the synthesis of RNA and DNA, RNA in the strongest inhibitory effect. Doxorubicin has an effect on a wide variety of tumor, belongs to the cycle non-specific drug, have all sorts of growth cycle of tumor cells to kill.it's given by injection into a vein.......
  • 2018-2023 Global Prostate Cancer Market Report (Status and Outlook)
    Published: 11-Oct-2018        Price: US 6990 Onwards        Pages: 117
    In this report, LP Information studies the present scenario (with the base year being 2017) and the growth prospects of global Prostate Cancer market for 2018-2023. Prostate cancer is cancer that occurs in the prostate. Over the next five years, LPI(LP Information) projects that Prostate Cancer will register a xx% CAGR in terms of revenue, reach US$ xx million by 2023, from US$ xx million in 2017. This report presents a comprehensive overview, market shares a......
  • 2018-2023 Global Docetaxel Consumption Market Report
    Published: 11-Oct-2018        Price: US 6990 Onwards        Pages: 137
    In this report, LP Information covers the present scenario (with the base year being 2017) and the growth prospects of global Docetaxel market for 2018-2023. Docetaxel is a chemotherapy medication used to treat a number of types of Cancer. This includes breast Cancer, head and neck Cancer, stomach Cancer, Prostate Cancer and non-small-cell lung Cancer. It may be used by itself or along with other chemotherapy medication. It is given by slow injection into a vein. The classi......
  • 2018-2023 United States Cancer Treatment Drugs Market Report (Status and Outlook)
    Published: 10-Oct-2018        Price: US 3360 Onwards        Pages: 88
    In 2017, the Cancer Treatment Drugs market size was xx million USD in United States, and it will be xx million USD in 2023, with a CAGR of xx% between 2017 and 2023. In United States market, the top players include - Roche - Novartis - Celgene - Bristol-Myers Squibb - Amgen - Johnson & Johnson - Pfizer - Takeda - Eli Lilly - AstraZeneca - Astellas - Merck & Co. - Sanofi - Bayer ......
  • 2018-2023 Philippines Cancer Treatment Drugs Market Report (Status and Outlook)
    Published: 10-Oct-2018        Price: US 3360 Onwards        Pages: 88
    In 2017, the Cancer Treatment Drugs market size was xx million USD in Philippines, and it will be xx million USD in 2023, with a CAGR of xx% between 2017 and 2023. In Philippines market, the top players include - Roche - Novartis - Celgene - Bristol-Myers Squibb - Amgen - Johnson & Johnson - Pfizer - Takeda - Eli Lilly - AstraZeneca - Astellas - Merck & Co. - Sanofi - Bayer - B......
  • 2018-2023 UK Cancer Treatment Drugs Market Report (Status and Outlook)
    Published: 10-Oct-2018        Price: US 3360 Onwards        Pages: 88
    In 2017, the Cancer Treatment Drugs market size was xx million USD in UK, and it will be xx million USD in 2023, with a CAGR of xx% between 2017 and 2023. In UK market, the top players include - Roche - Novartis - Celgene - Bristol-Myers Squibb - Amgen - Johnson & Johnson - Pfizer - Takeda - Eli Lilly - AstraZeneca - Astellas - Merck & Co. - Sanofi - Bayer - Biogen Idec ......
  • 2018-2023 India Cancer Treatment Drugs Market Report (Status and Outlook)
    Published: 10-Oct-2018        Price: US 3360 Onwards        Pages: 88
    In 2017, the Cancer Treatment Drugs market size was xx million USD in India, and it will be xx million USD in 2023, with a CAGR of xx% between 2017 and 2023. In India market, the top players include - Roche - Novartis - Celgene - Bristol-Myers Squibb - Amgen - Johnson & Johnson - Pfizer - Takeda - Eli Lilly - AstraZeneca - Astellas - Merck & Co. - Sanofi - Bayer - Biogen Idec......
  • Global Capecitabine Market Insights, Forecast to 2025
    Published: 08-Oct-2018        Price: US 3900 Onwards        Pages: 115
    This report studies the global market size of Capecitabine in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Capecitabine in these regions. This research report categorizes the global Capecitabine market by players/brands, region, type and application. This report also studies the global market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities......
  • Global Hydroxycarbamide Market Insights, Forecast to 2025
    Published: 08-Oct-2018        Price: US 3900 Onwards        Pages: 111
    This report studies the global market size of Hydroxycarbamide in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Hydroxycarbamide in these regions. This research report categorizes the global Hydroxycarbamide market by players/brands, region, type and application. This report also studies the global market status, competition landscape, market share, growth rate, future trends, market drivers, o......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - sales@rnrmarketresearch.com / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs